Canada markets close in 2 hours 20 minutes

PreveCeutical Medical Inc. (PRVCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01910.0000 (0.00%)
As of 01:03PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.0191
Open0.0161
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0161 - 0.0192
52 Week Range0.0117 - 0.0275
Volume27,000
Avg. Volume84,990
Market Cap9.91M
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-0.0040
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Article Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of Pharmacology

    Vancouver, British Columbia--(Newsfile Corp. - May 9, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that the British Journal of Pharmacology (the "BJP"), published an article on April 29, 2022, on the design and development of its non-addictive analgesic program ("Analgesic Program") under the running title, "Short dynorphin-like peptide agonists for kappa opioid receptors" click here to see the report. The art

  • Newsfile

    PreveCeutical Announces Debt Settlement and Conversion of Debt

    Vancouver, British Columbia--(Newsfile Corp. - March 30, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has issued 11,600,000 common shares without par value in its capital (each, a "Share") to two non-arm's length creditors and an arm's length creditor of the Company at a deemed issuance price of $0.025 per Share.The Company entered into shares for debt settlement agreements with a current director and ...

  • Newsfile

    Settlement Reached in Tietz Class Action Lawsuit

    Vancouver, British Columbia--(Newsfile Corp. - January 13, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the settlement of the proposed class action filed by Michael Tietz and Duane Loewen against the Company and many other parties in B.C. Supreme Court Action No. S197731, Vancouver Registry (the "Action").PreveCeutical commenced its own action against some of the defendants to the Action claiming damages for f